Tetraneuron closes a financing round of more than 2.5 million euros
Cajal Institute – News
Tetraneuron, the biotechnology company led by Dr. José María Frade, a researcher at the Cajal Institute, closes a round of financing of more than 2.5 million euros. ⠀
The Spanish biotech company, specialized in the research and development of a gene therapy for Alzheimer’s disease, is the first Spanish company to be accelerated by the Johnson&Johnson European Innovation Center.
For more information::
Tetraneuron, a spin-off company from José Mª Frade’s laboratory, is a resident company of Johnson & Johnson Innovation – JLABS
JLABS is a program of excellence for business incubation in life sciences. JLABS is a global network of open innovation ecosystems that enables and empowers innovators to create and accelerate the development of health and wellness solutions that improve the lives of patients around the world. As an innovation leader, JLABS helps entrepreneurs developing pharmaceutical, medical device, consumables and healthcare technology to deliver healthcare solutions to patients and consumers.